| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 38,901 | 31,253 | 37,665 | 55,341 | | Cost of Revenue | 29,152 | 24,786 | 29,932 | 41,953 | | | Gross Profit | 9,749 | 6,467 | 7,733 | 13,388 | | | Operating Expenses | | Research Development | 4,980 | 4,186 | 5,208 | 5,598 | | Selling General and Administrative | 5,958 | 6,408 | 7,301 | 8,202 | | Non Recurring | 710 |
-
|
-
| 25,338 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,899) | (4,127) | (4,776) | (25,750) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (68) | 282 | 582 | 1,256 | | Earnings Before Interest And Taxes | (1,967) | (3,845) | (4,194) | (24,494) | | Interest Expense |
-
|
-
|
-
| 96 | | Income Before Tax | (1,967) | (3,845) | (4,194) | (24,590) | | Income Tax Expense | 50 | (42) | (60) | 56 | | Minority Interest | 91 | (23) | 64 | (65) | | | | Net Income From Continuing Ops | (1,926) | (3,826) | (4,070) | (24,711) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,926) | (3,826) | (4,070) | (24,711) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,926) | ($3,826) | ($4,070) | ($24,711) |
|
0.51% Nasdaq 
0.01 (0.18%) 
Income Statement
